![Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-00603/article_deploy/html/images/pharmaceuticals-16-00603-g001.png)
Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders
![Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study - ScienceDirect Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0920996413003411-gr1.jpg)
Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study - ScienceDirect
![Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning | Psychiatrist.com Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2021/04/LU18052AH1F3.gif)
Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning | Psychiatrist.com
![Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis | Psychiatrist.com Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2021/06/20r02799T2.gif)
Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis | Psychiatrist.com
![Aripiprazole (Abilify) in the Treatment of People with Fragile X: An Anecdotal Account • FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome Aripiprazole (Abilify) in the Treatment of People with Fragile X: An Anecdotal Account • FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome](https://www.fraxa.org/wp-content/uploads/2020/07/An-Anecdotal-Account-of-Abilify-e1595895473519.jpg)
Aripiprazole (Abilify) in the Treatment of People with Fragile X: An Anecdotal Account • FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome
![Effectiveness of antipsychotic drugs in schizophrenia: a 10-year retrospective study in a Korean tertiary hospital | Schizophrenia Effectiveness of antipsychotic drugs in schizophrenia: a 10-year retrospective study in a Korean tertiary hospital | Schizophrenia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41537-020-00122-3/MediaObjects/41537_2020_122_Fig1_HTML.png)
Effectiveness of antipsychotic drugs in schizophrenia: a 10-year retrospective study in a Korean tertiary hospital | Schizophrenia
![Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study | Schizophrenia Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study | Schizophrenia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpjschz.2015.39/MediaObjects/41537_2015_Article_BFnpjschz201539_Fig1_HTML.jpg)
Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study | Schizophrenia
![Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis | Psychiatrist.com Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2021/06/20r02799T1.gif)
Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis | Psychiatrist.com
What are the negative effects of aripiprazole on teenagers brains? ( Permanent and temporary) - Quora
![PDF] Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents. | Semantic Scholar PDF] Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e3ffcdf6a791460fa6d254247612bd105ed84828/4-Table1-1.png)
PDF] Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents. | Semantic Scholar
![Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in ... Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in ...](https://www.jaacap.org/cms/attachment/9dd41fba-f360-4a18-9cf2-6f2075fd3f43/gr1.jpg)